Rankings
▼
Calendar
ALKS Q2 2025 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena
ALKS
Alkermes plc
$5B
Q2 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$391M
-2.1% YoY
Gross Profit
$341M
87.3% margin
Operating Income
$93M
23.8% margin
Net Income
$87M
22.3% margin
EPS (Diluted)
$0.52
QoQ Revenue Growth
+27.5%
Cash Flow
Operating Cash Flow
$150M
Free Cash Flow
$137M
Stock-Based Comp.
$25M
Balance Sheet
Total Assets
$2.3B
Total Liabilities
$628M
Stockholders' Equity
$1.6B
Cash & Equivalents
$521M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$391M
$399M
-2.1%
Gross Profit
$341M
$338M
+1.0%
Operating Income
$93M
$110M
-15.4%
Net Income
$87M
$91M
-4.7%
Revenue Segments
Product
$307M
50%
Vivitrol
$122M
20%
Aristada And Aristada Initio
$101M
16%
L Y B A L V I
$84M
14%
← FY 2025
All Quarters
Q3 2025 →